Cidara Therapeutics Investor Relations Material
Latest events
Status Update
Cidara Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cidara Therapeutics Inc
Access all reports
Cidara Therapeutics Inc. is a biotechnology company focused on developing anti-infective and immunotherapy treatments. The company specializes in long-acting antifungal and antiviral therapies, utilizing its proprietary drug-Fc conjugate (DFC) platform to enhance targeted immune responses. Its pipeline includes investigational treatments for serious fungal infections and viral diseases. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CDTX
Country
🇺🇸 United States